Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-893-9 | CAS number: 75-71-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian germ cell study: cytogenicity / chromosome aberration
- Remarks:
- Dominant Lethal Assay/chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Toxic effect type:
- concentration-driven
- Endpoint conclusion:
- no adverse effect observed
- Endpoint conclusion:
- no study available
- Endpoint conclusion:
- no study available
- Endpoint conclusion:
- no adverse effect observed
- Endpoint conclusion:
- no adverse effect observed
- Endpoint conclusion:
- no study available
No adverse effects were reported regarding reproductive parameters and/or reproductive organs based on tests conducted by the oral (3-generation study) and/or inhalation routes (2-year repeated dose toxicity study). There was no dominant lethal effect indicating no specific concern for male reproduction.
In a 3-generation oral study using CFC12 (in corn oil) at average doses of 15 and 150 mg/kg per day, Sherman (1974) found no adverse effects in reproductive capability as measured by the fertility index, gestation index, viability index and lactation index.
This study has been reviewed by the World Health Organisation (WHO) and international experts have agreed that no effects or dominant lethality was found at either dose level tested.
No effects were observed on fetal development in rats or rabbits exposed by the oral or inhalation routes.
Several studies conducted in the past in rats and rabbits were available and assessed as a weight of evidence because they did not fulfill the current standards and available documentation was limited. However the studies reports cited here were reviewed by international experts as part of the International Program on Chemical Safety and summarised in the Environmental Health Criteria document No.113: Fully halogenated chlorofluorocarbons (WHO/IPCS, 1990).
http://www.inchem.org/documents/ehc/ehc/ehc113.htm#PartNumber:7
One of the most relevant studies was undertaken, as part of a comprehensive toxicological program, to evaluate the embryotoxic and teratogenic potential of CFC-12 when administered by intragastric intubation to pregnant rats during the period of fetal organogenesis.
Gastric intubation of dichlorodifluoromethane (CFC-12) to pregnant rats from day six through day fifteen of their gestation period, at average dose levels of 16.6 and 170.9 mg/kg/day, had no effect on the food intake and the gain in body weight of the mothers.
No clinical signs of toxicity were observed in any of the treated animals. The outcome of pregnancy, measured by the number of implantation sites, resorptions and live foetuses per litter, was not adversely affected by the treatment. The treatment did not affect the embryonal development as measured by weight and crown-rump length of the foetuses. The absence of any major external, skeletal, and soft tissue abnormalities in live foetuses and a similar incidence of spontaneous minor anomalies in the control and treated groups indicate that oral administration for CFC-12 was not teratogenic.
CONCLUSIONS
The absence of any effect on the number of implantation sites, resorptions, live foetuses per litter and mean weight and crown-rump length of the foetuses indicate that maternal feeding of CFC-12 was not embryotoxic under the conditions of this experiment.
Likewise, the absence of any major abnormalities in live foetuses and a similar incidence of spontaneous minor anomalies in the control and treated groups indicate that CFC-12 was not teratogenic.
Other supporting studies:
In studies of inseminated Wistar albino rats and albino rabbits, Paulet et al. (1974) administered a mixture of 90% CFC-12 (dichlorodifluoromethane) and 10% Freon 11 by inhalation for 2hr/day. Rats were exposed on days 4 to 16 of gestation, and rabbits on days 5 to 20. The mixture was administered in a 20% concentration (200,000 ppm). No indications of any embryotoxic, fetotoxic, or teratogenic changes were found when dams were sacrificed and foetuses removed on day 20 of gestation (rats) or day 30 of gestation (rabbits). No classification is applicable.
In a study of a mixture (10% CFC-11 and 90% CFC-12), groups of rats and rabbits were exposed by inhalation on days 4-16 (rats) or days 5-20 (rabbits) of gestation for 2 h/day at a concentration of 989 g/m3(200 000 ppm). No evidence of embryotoxicity, fetotoxicity, or teratogenicity was seen when rats and rabbits were sacrificed at 20 days (rats) or 30 days (rabbits) of gestation. In addition, offspring of the dams that were allowed to deliver naturally showed no evidence of toxicity relative to survival or growth (US EPA, 1983). (possibly the same study by Paulet et al).
In a study, groups of 25 to 27 pregnant Charles River rats were given CFC-12 in corn oil by gavage at doses of 16.6 or 179 mg/kg per day on days 6-15 of gestation. Neither dose induced any evidence of embryotoxicity or teratogenicity (Sherman, 1974).
In conclusion, CFC-12 did not show any evidence of reproductive or developmental toxicity. No classification is applicable.
The above studies have all been ranked reliability 2 according to the Klimish et al system. This ranking was deemed appropriate because the studies were not conducted to GLP and are not in compliance with agreed protocols. However these are considered appropriate for use in assessment purposes in accordance with the criteria listed in Annex XI. As such, it is deemed appropriate to apply a weight of evidence approach based on similarity and animal welfare grounds.
The above results triggered no classification under the CLP Regulation (EC No 1272/2008). No classification for reproductive or developmental effects is therefore required.
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 974
- Reference Type:
- review article or handbook
- Title:
- MISCELLANEOUS FOOD ADDITIVES - DICHLORODIFLUOROMETHANE
- Author:
- Joint FAO/WHO Expert Committee on Food Additives
- Year:
- 1 975
- Bibliographic source:
- JECFA Toxicological evaluation of some food colours, thickening agents, and certain other substances; WHO FOOD ADDITIVES SERIES NO. 8
Materials and methods
- Principles of method if other than guideline:
- - Principle of test:
Dominant Lethal assay, part of a reproductive toxicity study.
- Short description of test conditions: The F0 animals of the reproduction study were mated to initiate an F1b litter. Animals were treated with the test substance gavage until pregnancies were terminated in mid-term to give a dominant lethal assay
- Parameters analysed / observed: fetal mortality - GLP compliance:
- not specified
- Remarks:
- Not likely (prior to GLP standards)
- Type of assay:
- rodent dominant lethal assay
Test material
- Reference substance name:
- Dichlorodifluoromethane
- EC Number:
- 200-893-9
- EC Name:
- Dichlorodifluoromethane
- Cas Number:
- 75-71-8
- Molecular formula:
- CCl2F2
- IUPAC Name:
- dichlorodifluoromethane
- Test material form:
- not specified
- Details on test material:
- Not specified
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on species / strain selection:
- Charles River CD
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle used: corn oil
- Duration of treatment / exposure:
- F0 animals were mater to initiate an F1b litter. Animals were treated by gavage until pregnancies were terminated in mid-term to give a dominant lethal assay.
- Frequency of treatment:
- Daily treatment for several weeks (no other details)
Doses / concentrationsopen allclose all
- Dose / conc.:
- 15 mg/kg bw/day
- Remarks:
- (or 0.2%)
- Dose / conc.:
- 150 mg/kg bw/day
- Remarks:
- (or 2%)
- No. of animals per sex per dose:
- no data
- Control animals:
- not specified
Examinations
- Evaluation criteria:
- fetal mortality
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
Applicant's summary and conclusion
- Conclusions:
- There was no evidence of adverse effects in the Dominant lethal assay, indicating that the substance did not cause chromosome damage to germ cells of the treated male rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
